Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Priyanka D. Patel; Pratiksha Patel; Yuanyuan Liang; James E. Meiring; Theresa Misiri; Felistas Mwakiseghile; J. Kathleen Tracy; Clemens Masesa; Harrison Msuku; David Banda; Maurice Mbewe; Marc Henrion; Fiyinfolu Adetunji; Kenneth Simiyu; Elizabeth Rotrosen; Megan Birkhold; Nginache Nampota; Osward M. Nyirenda; Karen Kotloff; Markus Gmeiner; Queen Dube; Gift Kawalazira; Matthew B. Laurens; Robert S. Heyderman; Melita A. Gordon; Kathleen M. Neuzil

Journal ArticleOPEN ACCESS

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Patel P
Patel P
Liang Y
et al.

New England Journal of Medicine (2021) 385(12) 1104-1115

DOI: 10.1056/nejmoa2035916

114Citations

131Readers

Abstract

Abstract Background Typhoid fever caused by multidrug-resistant H58 Salmonella Typhi is an increasing public health threat in sub-Saharan Africa. Methods We conducted a phase 3, double-blind trial ...

Cite

CITATION STYLE

APA

Patel, P. D., Patel, P., Liang, Y., Meiring, J. E., Misiri, T., Mwakiseghile, F., … Neuzil, K. M. (2021). Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children. New England Journal of Medicine, 385(12), 1104–1115. https://doi.org/10.1056/nejmoa2035916

Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children

Abstract

Cite

Register to see more suggestions